Crispr Therapeutics shares owned by SG Americas Securities
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by SG Americas Securities
from 13F filings
Historical chart of SG Americas Securities investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by SG Americas Securities
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 48k | 62.61 |
| 2023-09-30 | $1.1M | 23k | 45.37 |
| 2023-06-30 | $1.5M | 27k | 56.15 |
| 2023-03-31 | $1.2M | 27k | 45.24 |
| 2022-12-31 | $1.1M | 27k | 40.65 |
| 2022-09-30 | $839k | 13k | 65.34 |
| 2022-06-30 | $3.8M | 63k | 60.76 |
| 2022-03-31 | $279k | 4.4k | 62.74 |
| 2021-12-31 | $1.8M | 23k | 75.77 |
| 2021-09-30 | $8.1M | 72k | 111.93 |
| 2021-06-30 | $9.8M | 61k | 161.89 |
| 2021-03-31 | $7.3M | 60k | 121.86 |
| 2020-12-31 | $821k | 5.4k | 153.06 |
| 2020-09-30 | $578k | 6.9k | 83.68 |
| 2020-06-30 | $615k | 8.4k | 73.47 |
| 2019-12-31 | $401k | 6.6k | 60.90 |
| 2019-09-30 | $758k | 19k | 40.96 |